Phibro Animal Health (NASDAQ:PAHC) Sets New 52-Week High – Time to Buy?

Phibro Animal Health Co. (NASDAQ:PAHC) shares hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $26.55 and last traded at $26.14, with a volume of 82337 shares traded. The stock had previously closed at $25.77.

Wall Street Analysts Forecast Growth

A number of analysts have commented on PAHC shares. Morgan Stanley boosted their price target on shares of Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a research note on Tuesday, December 17th. StockNews.com lowered shares of Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a report on Thursday, February 6th. Finally, Barclays lifted their price target on Phibro Animal Health from $20.00 to $22.00 and gave the company an “underweight” rating in a research note on Monday, February 10th. Two analysts have rated the stock with a sell rating, two have issued a hold rating and one has issued a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $21.00.

Phibro Animal Health Stock Performance

The company has a debt-to-equity ratio of 2.99, a current ratio of 3.20 and a quick ratio of 1.69. The company’s fifty day moving average price is $22.17 and its 200 day moving average price is $21.99. The company has a market cap of $1.05 billion, a PE ratio of 53.79, a P/E/G ratio of 0.53 and a beta of 0.52.

Phibro Animal Health (NASDAQ:PAHC) last posted its quarterly earnings data on Wednesday, February 5th. The company reported $0.54 EPS for the quarter, beating the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. On average, equities research analysts predict that Phibro Animal Health Co. will post 1.94 earnings per share for the current year.

Phibro Animal Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Wednesday, March 5th will be paid a $0.12 dividend. The ex-dividend date is Wednesday, March 5th. This represents a $0.48 dividend on an annualized basis and a yield of 1.86%. Phibro Animal Health’s dividend payout ratio (DPR) is presently 100.00%.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Sterling Capital Management LLC lifted its stake in Phibro Animal Health by 2.4% in the fourth quarter. Sterling Capital Management LLC now owns 18,762 shares of the company’s stock valued at $394,000 after purchasing an additional 448 shares during the last quarter. Rhumbline Advisers lifted its position in shares of Phibro Animal Health by 0.6% during the 4th quarter. Rhumbline Advisers now owns 76,582 shares of the company’s stock valued at $1,608,000 after buying an additional 484 shares during the last quarter. Los Angeles Capital Management LLC grew its stake in shares of Phibro Animal Health by 2.1% during the 4th quarter. Los Angeles Capital Management LLC now owns 24,042 shares of the company’s stock worth $505,000 after acquiring an additional 503 shares during the period. BNP Paribas Financial Markets increased its holdings in Phibro Animal Health by 3.1% in the 3rd quarter. BNP Paribas Financial Markets now owns 24,336 shares of the company’s stock worth $548,000 after acquiring an additional 729 shares during the last quarter. Finally, New York State Teachers Retirement System raised its stake in Phibro Animal Health by 16.7% in the 4th quarter. New York State Teachers Retirement System now owns 5,428 shares of the company’s stock valued at $114,000 after acquiring an additional 775 shares during the period. 99.34% of the stock is owned by institutional investors.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.